Remove Marketing Remove Sales Remove Technical Review Remove Thousand Oaks
article thumbnail

Teledyne Cuts Outlook On Sales Slowdown In Energy Markets

socalTECH

Thousand Oaks-based Teledyne Technologies said this morning that it is cutting its outlook for the third quarter and full year, due to decline in sales in energy-related products. The company also blamed a strong U.S. dollar and "challenging" capital spending environment impacting its results.

Sales 100
article thumbnail

Teledyne Technologies Lops Employees, To Close Facilities

socalTECH

Thousand Oaks-based Teledyne Technologies , an aerospace and electronics firm, announced Wednesday that the firm has cut six percent of its North American workforce, eliminated salary increases, cut employee stock option awards, and will also close or relocate five of its operating sites, as it looks to cut expenses.

article thumbnail

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More

Xconomy

Then came the rumor mill: Companies may or may not be approaching Biogen about a sale, and Biogen may or may not be fielding offers. As a result, Biogen will buy the rights to nusinersen and prepare to ask regulators for marketing approval. SMA has no approved treatments. Regeneron is paying $25 million upfront.

News 40